DoubleLine ETF Adviser Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$9.94M |
| 2 |
Johnson & Johnson
JNJ
|
+$6.91M |
| 3 |
AbbVie
ABBV
|
+$4.84M |
| 4 |
Merck
MRK
|
+$3.57M |
| 5 |
UnitedHealth
UNH
|
+$3.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$9.5M |
| 2 |
Costco
COST
|
+$7.42M |
| 3 |
Procter & Gamble
PG
|
+$6.53M |
| 4 |
Coca-Cola
KO
|
+$5.28M |
| 5 |
Philip Morris
PM
|
+$4.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 25.27% |
| 2 | Consumer Discretionary | 25.11% |
| 3 | Healthcare | 24.95% |
| 4 | Real Estate | 24.36% |
| 5 | Technology | 0.24% |
Similar funds
DoubleLine ETF Adviser's Q1 2026 Portfolio in Review
As of Q1 2026, DoubleLine ETF Adviser held 216 positions worth $263M, down 21% from $333M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
DoubleLine ETF Adviser withdrew a net $56.9M in Q1 2026, closing 40 positions and reducing 121 holdings. Its most notable exit was Walmart Inc, an estimated $9.5M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 25% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, DoubleLine ETF Adviser opened a new position in Eli Lilly worth $9.02M.
- DoubleLine ETF Adviser's largest Q1 2026 buy was Eli Lilly: 9,802 shares worth $9.02M.
- DoubleLine ETF Adviser added most to Meta Platforms (Facebook) in Q1 2026, an estimated $2.37M increase.
- DoubleLine ETF Adviser's biggest Q1 2026 reduction was Warner Bros, cutting an estimated $3.03M.
- DoubleLine ETF Adviser fully exited Walmart Inc in Q1 2026, selling an estimated $9.5M.
- DoubleLine ETF Adviser's ten largest holdings make up 32% of its $263M portfolio in Q1 2026.
- DoubleLine ETF Adviser opened 49 new positions and closed 40 in Q1 2026.
- DoubleLine ETF Adviser's portfolio value fell 21% quarter-over-quarter to $263M.
Based on DoubleLine ETF Adviser's 13F filing for Q1 2026, filed 15 May 2026.